• BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference | Morningstar

    来源: Buzz FX / 08 11月 2024 08:11:28   America/New_York


    BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference - BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+) and prostate cancer (Bria-PROS+
    Read more...
分享